Long Non-coding RNAs and Their Roles in Non-small-cell Lung Cancer
- Author:
Wei MING-MING
1
;
Zhou GUANG-BIAO
Author Information
1. State Key Laboratory of Membrane Biology
- Keywords:
Long non-coding RNA;
Non-small-cell lung cancer;
Expression spectrum;
Biomarker;
Therapeutic resistance
- From:
Genomics, Proteomics & Bioinformatics
2016;14(5):280-288
- CountryChina
- Language:Chinese
-
Abstract:
As a leading cause of cancer deaths worldwide, lung cancer is a collection of diseases with diverse etiologies which can be broadly classified into small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). Lung cancer is characterized by genomic and epigenomic alter-ations; however, mechanisms underlying lung tumorigenesis remain to be elucidated. Long non-coding RNAs (lncRNAs) are a group of non-coding RNAs that consist of P200 nucleotides but possess low or no protein-coding potential. Accumulating evidence indicates that abnormal expres-sion of lncRNAs is associated with tumorigenesis of various cancers, including lung cancer, through multiple biological mechanisms involving epigenetic, transcriptional, and post-transcriptional alter-ations. In this review, we highlight the expression and roles of lncRNAs in NSCLC and discuss their potential clinical applications as diagnostic or prognostic biomarkers, as well as therapeutic targets.
